1.Application of machine learning models in predicting renal function decline following robot-assisted partial nephrectomy
Jing LI ; Linfeng WANG ; Gaojie ZHANG ; Yong HUANG ; Yingying GAO ; Rui SUN ; Yang CAO ; Qiuchen LI ; Hao HE ; Ziling WEI ; Jiayu LIU
Journal of Chongqing Medical University 2025;50(4):457-462
Objective:To compare the efficacy of various machine learning models in predicting renal function decline after robot-assisted partial nephrectomy(RAPN),and to provide evidence for clinical risk stratification.Methods:This study retrospectively in-cluded the clinical data of 733 patients with renal cell carcinoma undergoing RAPN at the Urology Department of The First Affiliated Hospital of Chongqing Medical University from January 2019 to December 2023.Demographic characteristics,laboratory indicators,and perioperative parameters were integrated to construct seven machine learning models.Key predictors were interpreted using Shap-ley additive explanations(SHAP).Model performance was evaluated using the area under the receiver operating characteristic curve(AUC).Results:The random forest model demonstrated the best predictive performance(AUC=0.84).SHAP analysis identified neutrophil-to-lymphocyte ratio,tumor diameter,the international normalized ratio of prothrombin time,white blood cell count,and in-traoperative blood loss as significant factors influencing postoperative renal function decline.Conclusion:This study provides a poten-tial predictive tool for clinical practice,aiding in identifying high-risk patients and optimizing postoperative management strategies.
2.Biomechanical Characteristics of Lower Limbs in Female Patients with Knee Osteoarthritis at the Beginning Stage of Learing Tai Chi Yunshou Movement
Ziling LIN ; Feng XIONG ; Meijin HOU ; Ye MA ; Benke LIU ; Bo CHEN ; Xiangbin WANG
Journal of Medical Biomechanics 2025;40(2):351-357
Objective To observe the differences in dynamic stability and kinematic/kinetic characteristics of the lower limbs between patients with knee osteoarthritis(KOA)and healthy individuals at the begining stage of practicing Tai Chi Yunshou movement.Methods Thirty Tai Chi beginners,including 15 patients with KOA and 15 healthy controls,were recruited to practice Tai Chi Yunshou movement for two hours under the guidance of a Tai Chi expert.A motion capture system and a three-dimensional force platform were used to collect and calculate dynamic stability parameter as well as kinematic and kinetic parameters of the left lower limb during the Yunshou movement.Results Compared with healthy controls,patients with KOA demonstrated a smaller center of mass(COM)-center of pressure(COP)inclination angle,reduced mean and peak ankle dorsiflexion angle,reduced peak hip adduction angle and increased peak knee flexion moment during the Yunshou movement(P<0.05).Conclusions Patients with KOA use adaptive postural strategies to maintain the lateral stability in Tai Chi Yunshou exercise,but a comprehensive training programme should be recommended to reduce the joint loading during flexion of the lower limbs at the benginning stages of this exercise.
3.Impact of of deep core muscle training on improving the motor control of load transfer activities in post-partum women with pelvic girdle pain
Yanping LIU ; Ziling LIN ; Yanjun HOU
Chinese Journal of Rehabilitation Medicine 2025;40(12):1796-1802
Objective:To investigate the effects of deep core muscle training on pain and motor control during load trans-fer activities in patients with postpartum pelvic girdle pain(PPGP),and to explore the potential mechanisms by which deep core stability training alleviates PPGP pain.Method:From July 2024 to April 2025,56 PPGP women at the Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine were randomly divided into a control group(n=28)and an experi-mental group(n=28).Both groups received conventional treatment,while the experimental group underwent deep core stability muscle training in addition to the conventional treatment,three times a week for eight con-secutive weeks.Before and after the treatment,real-time ultrasound was used to assess the thickness of the transversus abdominis muscle(TrA)during maximal expiratory contraction,the thickness during ASLR activity,priority activation rate,the elastic modulus,and the elastic velocity,which reflect the changes in the move-ment control ability of the TrA muscle.The pelvic girdle questionnaire(PGQ)was used to assess the changes in pain and functional impairment in patients,with pain intensity assessed using the visual analogue scale(VAS),and the ASLR score used to assess the changes in load transfer activity ability between the trunk and lower limbs.Result:After eight weeks of treatment,the thickness of the TrA contraction during maximal expiratory and ASLR activity in the experimental group was significantly greater than that in the control group(P<0.05),and the contraction rate during breathing and the pre-activation rate during activation were both significantly higher than those in the control group(P<0.05).The percentage of internal oblique muscle activation in the experimental group during maximal expiration was significantly lower than that in the control group(P<0.05).The elastic modulus of TrA in the experimental group at rest,during maximal expiration,and during ASLR testing were all significantly greater than those in the control group(P<0.05).In addition,the results of pain scores and functional scales showed that the VAS score,PGQ score,and the ASLR score in the experimental group were all significantly lower than those in the control group after intervention(P<0.05).Conclusion:The deep core muscle training program can effectively alleviate pain and improve function in pa-tients with PPGP,and its mechanism may be related to enhancing TrA function and the motor control during load-transfer activities in PPGP.
4.Progress of research on biofilm formation and treatment of Escherichia coli
Jingru ZHANG ; Zhenwei HUANG ; Ziling LIU
Chinese Journal of Nosocomiology 2025;35(14):2225-2229
The biofilm is a major pathogenic factor for many types of chronic infections,and Escherichia coli bio-film plays an important role in community-acquired infection and hospital-acquired infection and is one of common causes of urinary tract infection(UTI).The quorum sensing(QS)system of E.coli biofilm can mediate intercel-lular information exchange and thus regulate the whole community to adapt to the environmental changes,and the extracellular matrix-derived complex resistance mechanisms lead to a certain degree of bacterial resistance to anti-microbial drugs and resistance to immune system,which then makes it difficult for the conventional antimicrobial drugs to effectively eradicate the biofilm-associated infections.The article focuses on the formation of E.coli bio-film,drug resistance mechanisms and treatment aspects and summarizes the progress of research on the novel substitutive therapies against the E.coli biofilms that were developed in recent years,such as phytochemicals,nanomaterials,probiotics and phage therapy,so as to provide theoretical bases for the clinical treatment and the development of novel drug therapies against the E.coli biofilm.
5.Impact of of deep core muscle training on improving the motor control of load transfer activities in post-partum women with pelvic girdle pain
Yanping LIU ; Ziling LIN ; Yanjun HOU
Chinese Journal of Rehabilitation Medicine 2025;40(12):1796-1802
Objective:To investigate the effects of deep core muscle training on pain and motor control during load trans-fer activities in patients with postpartum pelvic girdle pain(PPGP),and to explore the potential mechanisms by which deep core stability training alleviates PPGP pain.Method:From July 2024 to April 2025,56 PPGP women at the Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine were randomly divided into a control group(n=28)and an experi-mental group(n=28).Both groups received conventional treatment,while the experimental group underwent deep core stability muscle training in addition to the conventional treatment,three times a week for eight con-secutive weeks.Before and after the treatment,real-time ultrasound was used to assess the thickness of the transversus abdominis muscle(TrA)during maximal expiratory contraction,the thickness during ASLR activity,priority activation rate,the elastic modulus,and the elastic velocity,which reflect the changes in the move-ment control ability of the TrA muscle.The pelvic girdle questionnaire(PGQ)was used to assess the changes in pain and functional impairment in patients,with pain intensity assessed using the visual analogue scale(VAS),and the ASLR score used to assess the changes in load transfer activity ability between the trunk and lower limbs.Result:After eight weeks of treatment,the thickness of the TrA contraction during maximal expiratory and ASLR activity in the experimental group was significantly greater than that in the control group(P<0.05),and the contraction rate during breathing and the pre-activation rate during activation were both significantly higher than those in the control group(P<0.05).The percentage of internal oblique muscle activation in the experimental group during maximal expiration was significantly lower than that in the control group(P<0.05).The elastic modulus of TrA in the experimental group at rest,during maximal expiration,and during ASLR testing were all significantly greater than those in the control group(P<0.05).In addition,the results of pain scores and functional scales showed that the VAS score,PGQ score,and the ASLR score in the experimental group were all significantly lower than those in the control group after intervention(P<0.05).Conclusion:The deep core muscle training program can effectively alleviate pain and improve function in pa-tients with PPGP,and its mechanism may be related to enhancing TrA function and the motor control during load-transfer activities in PPGP.
6.Progress of research on biofilm formation and treatment of Escherichia coli
Jingru ZHANG ; Zhenwei HUANG ; Ziling LIU
Chinese Journal of Nosocomiology 2025;35(14):2225-2229
The biofilm is a major pathogenic factor for many types of chronic infections,and Escherichia coli bio-film plays an important role in community-acquired infection and hospital-acquired infection and is one of common causes of urinary tract infection(UTI).The quorum sensing(QS)system of E.coli biofilm can mediate intercel-lular information exchange and thus regulate the whole community to adapt to the environmental changes,and the extracellular matrix-derived complex resistance mechanisms lead to a certain degree of bacterial resistance to anti-microbial drugs and resistance to immune system,which then makes it difficult for the conventional antimicrobial drugs to effectively eradicate the biofilm-associated infections.The article focuses on the formation of E.coli bio-film,drug resistance mechanisms and treatment aspects and summarizes the progress of research on the novel substitutive therapies against the E.coli biofilms that were developed in recent years,such as phytochemicals,nanomaterials,probiotics and phage therapy,so as to provide theoretical bases for the clinical treatment and the development of novel drug therapies against the E.coli biofilm.
7.Biomechanical Characteristics of Lower Limbs in Female Patients with Knee Osteoarthritis at the Beginning Stage of Learing Tai Chi Yunshou Movement
Ziling LIN ; Feng XIONG ; Meijin HOU ; Ye MA ; Benke LIU ; Bo CHEN ; Xiangbin WANG
Journal of Medical Biomechanics 2025;40(2):351-357
Objective To observe the differences in dynamic stability and kinematic/kinetic characteristics of the lower limbs between patients with knee osteoarthritis(KOA)and healthy individuals at the begining stage of practicing Tai Chi Yunshou movement.Methods Thirty Tai Chi beginners,including 15 patients with KOA and 15 healthy controls,were recruited to practice Tai Chi Yunshou movement for two hours under the guidance of a Tai Chi expert.A motion capture system and a three-dimensional force platform were used to collect and calculate dynamic stability parameter as well as kinematic and kinetic parameters of the left lower limb during the Yunshou movement.Results Compared with healthy controls,patients with KOA demonstrated a smaller center of mass(COM)-center of pressure(COP)inclination angle,reduced mean and peak ankle dorsiflexion angle,reduced peak hip adduction angle and increased peak knee flexion moment during the Yunshou movement(P<0.05).Conclusions Patients with KOA use adaptive postural strategies to maintain the lateral stability in Tai Chi Yunshou exercise,but a comprehensive training programme should be recommended to reduce the joint loading during flexion of the lower limbs at the benginning stages of this exercise.
8.Global Research Trends in Traditional Chinese Medicine and COVID-19: A Comprehensive Bibliometric and Visual Analysis.
Lei ZHANG ; Lin TONG ; Zihan JIA ; Dan LI ; Songwang WANG ; Qiujie CAI ; Sihong LIU ; Guangkun CHEN ; Ziling ZENG ; Hongjie GAO ; Yan MA ; Huamin ZHANG
Biomedical and Environmental Sciences 2024;37(11):1343-1347
9.First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial
Xiaohua WU ; Jihong LIU ; Ruifang AN ; Rutie YIN ; Yu ZHANG ; Huaijun ZHOU ; Aiqin HE ; Li WANG ; Jieqing ZHANG ; Ziling LIU ; Wei DUAN ; Jianqing ZHU ; Ge LOU ; Guilin CHEN ; Ying CHENG ; Fengxia XUE ; Sonja NICK ; Haiyan WANG ; Donghang LI
Journal of Gynecologic Oncology 2024;35(5):e99-
Objective:
First-line bevacizumab plus carboplatin and paclitaxel (CP) is approved for stage III/IV ovarian cancer treatment following initial surgical resection, based on global phase III GOG-0218 and ICON7 trials. This study evaluated the efficacy and safety of bevacizumab + CP as first-line ovarian cancer therapy in Chinese patients.
Methods:
Patients with newly diagnosed, International Federation of Gynecology and Obstetrics (FIGO) stage III/IV epithelial ovarian, fallopian tube, or primary peritoneal cancer post-primary surgery were randomized 1:1 to receive 6 cycles of CP with bevacizumab/ placebo, followed by bevacizumab/placebo maintenance until unacceptable toxicity or disease progression. Primary endpoint was investigator-assessed progression-free survival (PFS). Stratification factors were FIGO stage and debulking status (stage III optimally debulked vs stage III suboptimally debulked vs stage IV) and Eastern Cooperative Oncology Group performance status (0 vs 1 or 2).
Results:
Of randomized patients, 51 received bevacizumab + CP and 49 received placebo + CP. Median PFS was 22.6 months with bevacizumab + CP (95% confidence interval [CI]=18.6, not estimable) and 12.3 months (95% CI=9.5, 15.0) with placebo + CP (stratified hazard ratio=0.30; 95% CI=0.17, 0.53). Treatment-related grade 3/4 adverse events occurred in 46 of 49 (94%) patients receiving bevacizumab + CP, and 34 of 50 (68%) receiving placebo + CP.
Conclusion
Bevacizumab + CP showed clinically meaningful improvement in PFS vs placebo + CP, consistent with GOG-0218 results. Safety data were aligned with the known bevacizumab safety profile. These results support first-line bevacizumab + CP therapy in Chinese patients with ovarian cancer.
10.First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial
Xiaohua WU ; Jihong LIU ; Ruifang AN ; Rutie YIN ; Yu ZHANG ; Huaijun ZHOU ; Aiqin HE ; Li WANG ; Jieqing ZHANG ; Ziling LIU ; Wei DUAN ; Jianqing ZHU ; Ge LOU ; Guilin CHEN ; Ying CHENG ; Fengxia XUE ; Sonja NICK ; Haiyan WANG ; Donghang LI
Journal of Gynecologic Oncology 2024;35(5):e99-
Objective:
First-line bevacizumab plus carboplatin and paclitaxel (CP) is approved for stage III/IV ovarian cancer treatment following initial surgical resection, based on global phase III GOG-0218 and ICON7 trials. This study evaluated the efficacy and safety of bevacizumab + CP as first-line ovarian cancer therapy in Chinese patients.
Methods:
Patients with newly diagnosed, International Federation of Gynecology and Obstetrics (FIGO) stage III/IV epithelial ovarian, fallopian tube, or primary peritoneal cancer post-primary surgery were randomized 1:1 to receive 6 cycles of CP with bevacizumab/ placebo, followed by bevacizumab/placebo maintenance until unacceptable toxicity or disease progression. Primary endpoint was investigator-assessed progression-free survival (PFS). Stratification factors were FIGO stage and debulking status (stage III optimally debulked vs stage III suboptimally debulked vs stage IV) and Eastern Cooperative Oncology Group performance status (0 vs 1 or 2).
Results:
Of randomized patients, 51 received bevacizumab + CP and 49 received placebo + CP. Median PFS was 22.6 months with bevacizumab + CP (95% confidence interval [CI]=18.6, not estimable) and 12.3 months (95% CI=9.5, 15.0) with placebo + CP (stratified hazard ratio=0.30; 95% CI=0.17, 0.53). Treatment-related grade 3/4 adverse events occurred in 46 of 49 (94%) patients receiving bevacizumab + CP, and 34 of 50 (68%) receiving placebo + CP.
Conclusion
Bevacizumab + CP showed clinically meaningful improvement in PFS vs placebo + CP, consistent with GOG-0218 results. Safety data were aligned with the known bevacizumab safety profile. These results support first-line bevacizumab + CP therapy in Chinese patients with ovarian cancer.

Result Analysis
Print
Save
E-mail